vTv Therapeutics Inc sell nvestor
Start price
12.12.20
/
50%
€2.30
Target price
12.12.21
€1.00
Performance (%)
-14.22%
End price
26.06.21
€1.97
Summary
This prediction ended on 26.06.21 with a price of €1.97. The prediction for vTv Therapeutics Inc closed with a convincing performance of -14.22%. nvestor has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
vTv Therapeutics Inc | - | - | - | - |
iShares Core DAX® | 1.056% | 1.056% | 18.108% | 16.006% |
iShares Nasdaq 100 | -1.886% | -0.160% | 26.970% | 36.233% |
iShares Nikkei 225® | 2.553% | 4.359% | 17.676% | 10.955% |
iShares S&P 500 | -0.434% | 0.224% | 24.986% | 37.667% |
According to nvestor what are the pros and cons of vTv Therapeutics Inc for the foreseeable future?
Pros
Cons
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
overvalued
Very low/no dividend yield expected
Decining EBIT margin than peer group
very negative Cash Flow expected
Very little Investments for future growth
High risks in the balance sheet
ROE lower than 5% per year
High challenges to pay loans and raise capital
Very bad culture
No Innovation
Dependend from few customers or products
Growths much slower than the competition
Mainly gamblers invest here
Junk rating
Deficits in Management
No uniques
Sustainability is not important
High risks for its business
Nicheplayer
Very high cyclical dependencies
Unknown brand
Outdated or very high risk business model
Comments by nvestor for this prediction
In the thread vTv Therapeutics Inc diskutieren
Sell mit Kursziel 1,0
In the thread Trading vTv Therapeutics Inc
Sell beendet